Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Arbutus Biopharma Corp

Arbutus Biopharma Corp (ABUS)

Market is closed
News
Is Arbutus Biopharma Corp (ABUS) Worthy of Your Portfolio?

Is Arbutus Biopharma Corp (ABUS) Worthy of Your Portfolio?

Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money because they are without...

Keep Reading →

December 12th, 2016 - Hedge Funds News

Arbutus Biopharma Corp (ABUS): Are Hedge Funds Right About This Stock?

Arbutus Biopharma Corp (ABUS): Are Hedge Funds Right About This Stock?

Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don...

Keep Reading →

November 29th, 2015 - Hedge Funds News

Insider Monkey Quarterly Strategy
+334.6% Insider Monkey Quarterly Strategy
+149.4% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)